Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2017 | Pages:
101 | Publisher: QYResearch
Industry: Chemicals & Materials | Report Format: Electronic (PDF)
This report studies Vaccine Conjugate in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Merck & Co., Inc.
GlaxoSmithKline plc.
SutroVax Inc.
Fablife.
Pfizer
Sinovac Biotech Ltd.
Sanofi Pasteur SA.
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Monovalent
Multivalent
Others
By Application, the market can be split into
Influenza
Meningococcal
Pneumococcal
Others
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Vaccine Conjugate Market Professional Survey Report 2017
1 Industry Overview of Vaccine Conjugate
1.1 Definition and Specifications of Vaccine Conjugate
1.1.1 Definition of Vaccine Conjugate
1.1.2 Specifications of Vaccine Conjugate
1.2 Classification of Vaccine Conjugate
1.2.1 Monovalent
1.2.2 Multivalent
1.2.3 Others
1.3 Applications of Vaccine Conjugate
1.3.1 Influenza
1.3.2 Meningococcal
1.3.3 Pneumococcal
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Vaccine Conjugate
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Vaccine Conjugate
2.3 Manufacturing Process Analysis of Vaccine Conjugate
2.4 Industry Chain Structure of Vaccine Conjugate
3 Technical Data and Manufacturing Plants Analysis of Vaccine Conjugate
3.1 Capacity and Commercial Production Date of Global Vaccine Conjugate Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Vaccine Conjugate Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Vaccine Conjugate Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Vaccine Conjugate Major Manufacturers in 2016
4 Global Vaccine Conjugate Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Vaccine Conjugate Capacity and Growth Rate Analysis
4.2.2 2016 Vaccine Conjugate Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Vaccine Conjugate Sales and Growth Rate Analysis
4.3.2 2016 Vaccine Conjugate Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Vaccine Conjugate Sales Price
4.4.2 2016 Vaccine Conjugate Sales Price Analysis (Company Segment)
5 Vaccine Conjugate Regional Market Analysis
5.1 North America Vaccine Conjugate Market Analysis
5.1.1 North America Vaccine Conjugate Market Overview
5.1.2 North America 2012-2017E Vaccine Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Vaccine Conjugate Sales Price Analysis
5.1.4 North America 2016 Vaccine Conjugate Market Share Analysis
5.2 China Vaccine Conjugate Market Analysis
5.2.1 China Vaccine Conjugate Market Overview
5.2.2 China 2012-2017E Vaccine Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Vaccine Conjugate Sales Price Analysis
5.2.4 China 2016 Vaccine Conjugate Market Share Analysis
5.3 Europe Vaccine Conjugate Market Analysis
5.3.1 Europe Vaccine Conjugate Market Overview
5.3.2 Europe 2012-2017E Vaccine Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Vaccine Conjugate Sales Price Analysis
5.3.4 Europe 2016 Vaccine Conjugate Market Share Analysis
5.4 Southeast Asia Vaccine Conjugate Market Analysis
5.4.1 Southeast Asia Vaccine Conjugate Market Overview
5.4.2 Southeast Asia 2012-2017E Vaccine Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Vaccine Conjugate Sales Price Analysis
5.4.4 Southeast Asia 2016 Vaccine Conjugate Market Share Analysis
5.5 Japan Vaccine Conjugate Market Analysis
5.5.1 Japan Vaccine Conjugate Market Overview
5.5.2 Japan 2012-2017E Vaccine Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Vaccine Conjugate Sales Price Analysis
5.5.4 Japan 2016 Vaccine Conjugate Market Share Analysis
5.6 India Vaccine Conjugate Market Analysis
5.6.1 India Vaccine Conjugate Market Overview
5.6.2 India 2012-2017E Vaccine Conjugate Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Vaccine Conjugate Sales Price Analysis
5.6.4 India 2016 Vaccine Conjugate Market Share Analysis
6 Global 2012-2017E Vaccine Conjugate Segment Market Analysis (by Type)
6.1 Global 2012-2017E Vaccine Conjugate Sales by Type
6.2 Different Types of Vaccine Conjugate Product Interview Price Analysis
6.3 Different Types of Vaccine Conjugate Product Driving Factors Analysis
6.3.1 Monovalent of Vaccine Conjugate Growth Driving Factor Analysis
6.3.2 Multivalent of Vaccine Conjugate Growth Driving Factor Analysis
6.3.3 Others of Vaccine Conjugate Growth Driving Factor Analysis
7 Global 2012-2017E Vaccine Conjugate Segment Market Analysis (by Application)
7.1 Global 2012-2017E Vaccine Conjugate Consumption by Application
7.2 Different Application of Vaccine Conjugate Product Interview Price Analysis
7.3 Different Application of Vaccine Conjugate Product Driving Factors Analysis
7.3.1 Influenza of Vaccine Conjugate Growth Driving Factor Analysis
7.3.2 Meningococcal of Vaccine Conjugate Growth Driving Factor Analysis
7.3.3 Pneumococcal of Vaccine Conjugate Growth Driving Factor Analysis
7.3.4 Others of Vaccine Conjugate Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Vaccine Conjugate
8.1 Merck & Co., Inc.
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Merck & Co., Inc. 2016 Vaccine Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Merck & Co., Inc. 2016 Vaccine Conjugate Business Region Distribution Analysis
8.2 GlaxoSmithKline plc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 GlaxoSmithKline plc. 2016 Vaccine Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 GlaxoSmithKline plc. 2016 Vaccine Conjugate Business Region Distribution Analysis
8.3 SutroVax Inc.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 SutroVax Inc. 2016 Vaccine Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 SutroVax Inc. 2016 Vaccine Conjugate Business Region Distribution Analysis
8.4 Fablife.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Fablife. 2016 Vaccine Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Fablife. 2016 Vaccine Conjugate Business Region Distribution Analysis
8.5 Pfizer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Pfizer 2016 Vaccine Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Pfizer 2016 Vaccine Conjugate Business Region Distribution Analysis
8.6 Sinovac Biotech Ltd.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Sinovac Biotech Ltd. 2016 Vaccine Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Sinovac Biotech Ltd. 2016 Vaccine Conjugate Business Region Distribution Analysis
8.7 Sanofi Pasteur SA.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Sanofi Pasteur SA. 2016 Vaccine Conjugate Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sanofi Pasteur SA. 2016 Vaccine Conjugate Business Region Distribution Analysis
9 Development Trend of Analysis of Vaccine Conjugate Market
9.1 Global Vaccine Conjugate Market Trend Analysis
9.1.1 Global 2017-2022 Vaccine Conjugate Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Vaccine Conjugate Sales Price Forecast
9.2 Vaccine Conjugate Regional Market Trend
9.2.1 North America 2017-2022 Vaccine Conjugate Consumption Forecast
9.2.2 China 2017-2022 Vaccine Conjugate Consumption Forecast
9.2.3 Europe 2017-2022 Vaccine Conjugate Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Vaccine Conjugate Consumption Forecast
9.2.5 Japan 2017-2022 Vaccine Conjugate Consumption Forecast
9.2.6 India 2017-2022 Vaccine Conjugate Consumption Forecast
9.3 Vaccine Conjugate Market Trend (Product Type)
9.4 Vaccine Conjugate Market Trend (Application)
10 Vaccine Conjugate Marketing Type Analysis
10.1 Vaccine Conjugate Regional Marketing Type Analysis
10.2 Vaccine Conjugate International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Vaccine Conjugate by Region
10.4 Vaccine Conjugate Supply Chain Analysis
11 Consumers Analysis of Vaccine Conjugate
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Vaccine Conjugate Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Vaccine Conjugate
Table Product Specifications of Vaccine Conjugate
Table Classification of Vaccine Conjugate
Figure Global Production Market Share of Vaccine Conjugate by Type in 2016
Figure Monovalent Picture
Table Major Manufacturers of Monovalent
Figure Multivalent Picture
Table Major Manufacturers of Multivalent
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Vaccine Conjugate
Figure Global Consumption Volume Market Share of Vaccine Conjugate by Application in 2016
Figure Influenza Examples
Table Major Consumers in Influenza
Figure Meningococcal Examples
Table Major Consumers in Meningococcal
Figure Pneumococcal Examples
Table Major Consumers in Pneumococcal
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Vaccine Conjugate by Regions
Figure North America Vaccine Conjugate Market Size (Million USD) (2012-2022)
Figure China Vaccine Conjugate Market Size (Million USD) (2012-2022)
Figure Europe Vaccine Conjugate Market Size (Million USD) (2012-2022)
Figure Southeast Asia Vaccine Conjugate Market Size (Million USD) (2012-2022)
Figure Japan Vaccine Conjugate Market Size (Million USD) (2012-2022)
Figure India Vaccine Conjugate Market Size (Million USD) (2012-2022)
Table Vaccine Conjugate Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Vaccine Conjugate in 2016
Figure Manufacturing Process Analysis of Vaccine Conjugate
Figure Industry Chain Structure of Vaccine Conjugate
Table Capacity and Commercial Production Date of Global Vaccine Conjugate Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Vaccine Conjugate Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Vaccine Conjugate Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Vaccine Conjugate Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Vaccine Conjugate 2012-2017
Figure Global 2012-2017E Vaccine Conjugate Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Vaccine Conjugate Market Size (Value) and Growth Rate
Table 2012-2017E Global Vaccine Conjugate Capacity and Growth Rate
Table 2016 Global Vaccine Conjugate Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Vaccine Conjugate Sales (K MT) and Growth Rate
Table 2016 Global Vaccine Conjugate Sales (K MT) List (Company Segment)
Table 2012-2017E Global Vaccine Conjugate Sales Price (USD/MT)
Table 2016 Global Vaccine Conjugate Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Vaccine Conjugate 2012-2017E
Figure North America 2012-2017E Vaccine Conjugate Sales Price (USD/MT)
Figure North America 2016 Vaccine Conjugate Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Vaccine Conjugate 2012-2017E
Figure China 2012-2017E Vaccine Conjugate Sales Price (USD/MT)
Figure China 2016 Vaccine Conjugate Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Vaccine Conjugate 2012-2017E
Figure Europe 2012-2017E Vaccine Conjugate Sales Price (USD/MT)
Figure Europe 2016 Vaccine Conjugate Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Vaccine Conjugate 2012-2017E
Figure Southeast Asia 2012-2017E Vaccine Conjugate Sales Price (USD/MT)
Figure Southeast Asia 2016 Vaccine Conjugate Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Vaccine Conjugate 2012-2017E
Figure Japan 2012-2017E Vaccine Conjugate Sales Price (USD/MT)
Figure Japan 2016 Vaccine Conjugate Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Vaccine Conjugate 2012-2017E
Figure India 2012-2017E Vaccine Conjugate Sales Price (USD/MT)
Figure India 2016 Vaccine Conjugate Sales Market Share
Table Global 2012-2017E Vaccine Conjugate Sales (K MT) by Type
Table Different Types Vaccine Conjugate Product Interview Price
Table Global 2012-2017E Vaccine Conjugate Sales (K MT) by Application
Table Different Application Vaccine Conjugate Product Interview Price
Table Merck & Co., Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co., Inc. Vaccine Conjugate Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Merck & Co., Inc. Vaccine Conjugate Business Region Distribution
Table GlaxoSmithKline plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline plc. Vaccine Conjugate Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 GlaxoSmithKline plc. Vaccine Conjugate Business Region Distribution
Table SutroVax Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2015 SutroVax Inc. Vaccine Conjugate Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 SutroVax Inc. Vaccine Conjugate Business Region Distribution
Table Fablife. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Fablife. Vaccine Conjugate Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Fablife. Vaccine Conjugate Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Vaccine Conjugate Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Vaccine Conjugate Business Region Distribution
Table Sinovac Biotech Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sinovac Biotech Ltd. Vaccine Conjugate Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sinovac Biotech Ltd. Vaccine Conjugate Business Region Distribution
Table Sanofi Pasteur SA. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Pasteur SA. Vaccine Conjugate Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sanofi Pasteur SA. Vaccine Conjugate Business Region Distribution
Figure Global 2017-2022 Vaccine Conjugate Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Vaccine Conjugate Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Vaccine Conjugate Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Vaccine Conjugate Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Vaccine Conjugate Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Vaccine Conjugate Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Vaccine Conjugate Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Vaccine Conjugate Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Vaccine Conjugate Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Vaccine Conjugate by Type 2017-2022
Table Global Consumption Volume (K MT) of Vaccine Conjugate by Application 2017-2022
Table Traders or Distributors with Contact Information of Vaccine Conjugate by Region
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
